Acurx Pharmaceuticals

/Acurx Pharmaceuticals

IPO

Acurx Pharmaceuticals

Biopharmaceutical

We are a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization (“WHO”), the U.S. Centers for Disease Control and Prevention (“CDC”), and the U.S. Food and Drug Administration (“FDA”).

Symbol

ACXP

Price Range
$5.00 - $7.00

Final Shares
2,500,000

Anticipated Date
June 25, 2021

Underwriters
ALEXANDER CAPITAL, L.P.

This offering is no longer available

To view the prospectus for Acurx Pharmaceuticals IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange